Adgero Biopharmaceuticals Holdings, Inc. — Form D
Adgero Biopharmaceuticals Holdings, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-24. The offering totals $50K, of which $40K was reported sold. Industry: Investing.
Offering
- Filed: 2015-11-24
- Form: D
- Accession: 0001657598-15-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $50K
- Amount sold: $40K
- Remaining: $10K
- Investors: 9
- Date of first sale: 2015-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-251777
Issuer
- Name: Adgero Biopharmaceuticals Holdings, Inc.
- CIK: 0001657598
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 301 N. HARRISON ST., PRINCETON, NJ, 08540
- Phone: 609-275-6837
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| David Hochman | Director | Cleveland, OH |
| John Brancaccio | Executive Officer | San Diego, CA |
| David Hochman | Executive Officer | Cleveland, OH |
| David P Hochman | Director | New Hope, PA |
| Steve P Rychnovsky | Executive Officer | Princeton, NJ |
| Tim P McInerney | Director | Princeton, NJ |
| Frank P Pilkiewicz | Director | Princeton, NJ |
| Frank P Pilkiewicz | Executive Officer | Princeton, NJ |
| Allen P Bloom | Director | Princeton, NJ |
| Roman P Perez-Soler | Director | Princeton, NJ |
Other filings by this issuer (2)
More